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TransplantatABSTRACT
Tissue engineering has emerged as a new approach with the potential to overcome the
limitations of traditional therapies. The objective of this study was to test whether our
polymeric scaffold is able to resist the corrosive action of bile and to support a cell’s
inﬁltration and neoangiogenesis with the aim of using it as a biodegradable tissue substitute
for serious bile duct injuries. In particular, a resorbable electrospun polyhydroxyethyl-
aspartamideepolylactic acid (90mol% PHEA, 10mol% PLA)/polycaprolactone (50:50 w/w)
plate scaffold was implanted into rabbit gallbladder to assess the in vivo effects of the lytic
action of the bile on the scaffold structure and then as a tubular scaffold to create a biliary-
digestive anastomosis as well. For the above evaluation, 5 animals were used and killed
after 15 days and 5 animals after 3 months. At 15-day and 3-month follow-ups, the ﬁbrillar
structurewas not digested by lytic action bile. Theﬁbers of the scaffoldwere organized despite
being in contact with bile action. A new epithelial tissue appeared on the scaffold surface
suggesting the suitability of this scaffold for future studies of the repair of biliary tract injuries
with the use of resorbable copolymer on biliary injuries.Funding: PRIN 2015: “Chirurgia rigenerativa nei difetti della
parete addominale e nel deﬁcit congenito o acquisito delle vie
escretrici urinarie, biliari e dei vasi sanguigni: modellamento e
crescita cellulare su scaffold planare e su scaffold tubulare.
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buscemi.salvatore@gmail.comEXTRAHEPATIC biliary tract lesions occurring duringlaparoscopic cholecystectomy are burdened by peri-
operative morbidity and mortality [1,2], reduction of long-
term survival [3], and reduction of the patient’s quality of
life [4,5]. Although the incidence of biliary injury during
laparotomy is 0.1%e0.2% [6], in the case of the laparoscopic
approach it becomes w2-fold or even 3-fold higher [7].
Various attempts have been made to reconstruct the bile
duct with the use of nonabsorbable vascular grafts, such
as expanded polytetraﬂuoroethylene, with unsatisfactory
results due to a high rate of stenosis, early-occurring
infections, and long-term foreign body reactions [8e12].
Autologous grafts have been proposed as possible prosthetic
material, but they showed extremely low results in the long
term [13e16].
Rosen et al [17] described a method of biliary tree
regeneration using the porcine small intestinal submucosa,
another alternate material that does not involve any foreign
body reaction but is burdened by the risk of zoonoses and
abnormal wound healing [18,19].vier Inc. All rights reserved.
enue, New York, NY 10169
ion Proceedings, 49, 711e715 (2017)At present the criterion-standard surgical option is the
creation of derivative biliary-digestive anastomoses: never-
theless, this kind of intervention does not restore a complete
physiologic anatomy and is burdened by a high rate of
morbidity and mortality with a consequent reduction in the
patient’s quality of life. The approach of regenerative
medicine could be the most simple and effective solution for
the repair of iatrogenic lesions of the biliary tract [20e23].
The tissue engineering approach requires the use of
biodegradable scaffolds to allow cell recruitment from the0041-1345/17
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Fig 1. Biliodigestive anastomosis with the use of PHEA-PLA/
PCL tubular scaffold.
712 BUSCEMI, DAMIANO, FAZZOTTA ET ALboundary tissues, their proliferation stimulating new capil-
lary formation in the ﬁrst post-implantation phase and
allowing the deposition of new extracellular matrix thanks
to its progressive reabsorption [24]. Some polymeric mate-
rials have already been proposed as artiﬁcial substitutes of
both natural and synthetic bile ducts [25,26]. Zong et al
focused on the necessity of the scaffold not only being a
passive conduit to allow bile ﬂux, but also potentially sup-
porting cell penetration, adhesion, and differentiation, as
well as its degradation within the given time [27].
Our research group has proposed the use of electrospun
biomaterials made of a,b-poly(N-2-hydroxyethyl-D,L)-
aspartamide (PHEA)epolylactic acid (PLA) as scaffold for
different regenerative purposes. Electrospun PHEA-PLA
scaffolds were assayed in vitro to test the ability to sup-
port cell attachment and proliferation. Moreover, the
chemical reactivity of PHEA repetitive units was exploited
to link biologic effectors such as heparin and antiin-
ﬂammatory drugs [28,29]. Recently, biocompatibility of
hybrid ﬁbers of PHEA-PLA/polycaprolactone (PCL) were
tested in vivo in a murine model [30,31].
We report the ﬁrst application of PHEA-PLA/PCL scaf-
folds in the repair of a biliary duct in an animal model. The
aim was to test the scaffold resistance to the chemical action
of bile juice and its ability to attract cell implantation as
ﬁbroblasts and neovascularization.METHODS
The PHEA-PLA was synthesized according to a procedure
described in previous works [32e34]. PCL was dissolved in a 50:50
(v/v) mixture of dichloromethane/dichloromethane with a concen-
tration of 10% (w/v). Then, the solution was used to dissolve
PHEA-PLA copolymer to obtain a weight ratio of PHEA-PLA and
PCL of 50:50. The electrospinning process was carried out hori-
zontally with an accelerating voltage ranging from 20 to 25 kV and a
constant polymeric solution rate of 1 mL/h. The electrospun scaf-
fold was collected on aluminum foil wrapped around an grounded
rotating collector (200 rpm) 10e20 cm from the tip of the needle.
The resulting ﬁbrillar scaffold was washed with double-distilled
water then dried under vacuum at room temperature for 4 days.
Ten New Zealand white male rabbits weighing w1.5 kg were
used. The animals were sedated with the use of intramuscular in-
jections of 80 g/kg medetomidine and a solution of tiletamine and
zolazepam to 4 mg/kg; anesthesia was induced and maintained with
the use of a gaseous mixture of isoﬂurane and oxygen administered
by means of facemask. After a median laparotomy, each rabbit’s
gallbladder was isolated and incised. The gallbladder was washed
and a PHEA-PLA/PCL patch (1 cm  1 cm) was inserted in the
organ. The scaffold was then secured to the wall, including part of it
in the suture of the previously performed incision. The median
laparotomy was then closed and the animals kept fasting for the
following 12 hours. An antibiotic was administrated for 4 days after
the intervention. Fifteen days after the intervention, 4 rabbits were
killed, and the scaffold patch taken from the animals’ gallbladder
was cleaned by means of repeated washings with a physiologic saline
solution for it to be analyzed with the use of scanning electron
microscopy (SEM) and a histologic examination. The same
procedure was repeated after 3 months for the other group of
4 animals. Two animals were used as control in which noimplantation was carried out; they were subsequently killed at 15
days and 3 months. In the 2nd part of our experiment, 4 New
Zealand white male rabbits weighingw1.5 kg were used. After the
sedation and the induction of anesthesia in the rabbits, we per-
formed a biliary-digestive anastomosis between the fundus of the
gallbladder and the second duodenal portion. After ligation of the
common bile duct, we carried out an anastomosis with the inter-
position of the PHEA-PLA/PCL tubular scaffold, sutured with the
use of polypropylene 7-0 (Fig 1).
An antibiotic was administrated for 4 days after the intervention.
Three months after the intervention, all of the rabbits were killed
and the scaffold taken en bloc from each animal’s abdomen. One
animal was used as control.
All animal experiments were in compliance with the Animal
Research: Reporting of In Vivo Experiments guidelines and were
carried out in accordance with the EU Directive 2010/63/EU
guidelines for animal experiments, the National Institutes of Health
guide for the care and use of laboratory animals (legislative decree
no 26, March 4, 2014) and the Organismo Preposto al Benessere
Animale of the “A. Mirri” Zooprophylactic Institute.
Five-mm thick sections were obtained from the formalin-ﬁxed
parafﬁn-embedded samples 3 months after the implantation; they
were then set on slides treated with silane (3-aminopropyl-trieossi-
silane) to avoid detachment during staining. The preparations
obtained were dried overnight in an oven at 37C, then a dewaxing
with the use of xylene was performed for 20 minutes. After a
descending alcohol series (100%, 95%, 75%, and 50%), the slides
were washed in distilled water and then stained with hematoxylin
and eosin. This was followed by the ascending scale of alcohols
(50%, 75%, 95%, and 100%) and clariﬁcation in xylene. After this
phase, the slides were mounted in an acrylic mounting medium
(Eukitt; O. Kindler).
RESULTS
SEM analysis revealed that the side of the scaffold patch in
contact with the gallbladder lumen appeared inter-
penetrated with cellular and extracellular materials. The
side pointed toward the lumen of the gallbladder main-
tained its ﬁbrillarity. The ﬁbers appeared unchanged in form
and dimension and showed uniformity in size and absence
of fusion among each other. The 3-dimensional microﬁ-
brillar structure of the scaffold patch was maintained and
Fig 2. (A) SEM image of PHEA-PLA PCL scaffold after 15 days of implantation in rabbit gallbladder (500). (B) SEM image of PHEA-
PLA/PCL scaffold after 3 months of implantation in rabbit gallbladder (10,000).
PHEA-PLA/PCL SCAFFOLD FOR BILIARY DUCT REPAIR 713therefore was not damaged by the lytic action of bile after 15
days nor after 3 months (Fig 2).
The eosin-hematoxylin stain of samples excised from the
gallbladder after 3 months showed that the electrospun
scaffold was covered with the mucosal tissue and a correct
stratiﬁcation of epithelial cells. The boundary between
epithelia and scaffold was clearly visible and looked like a
cellular inﬁltration on the scaffold made up of ﬁbrous tissueFig. 3. Eosin-hematoxylin stain of sand inﬂammatory cells (Fig 3A). At higher magniﬁcation, it
was possible to observe lymphocytes, macrophages, and
giant cells in the cellular inﬁltrate (Fig 3B). This aspect was
consistent with a foreign body reaction elicited by the
scaffold. In Fig 3C it is possible to observe the formation of
neovasa in the scaffold.
In the samples of tubular scaffold 3 months after
implantation, there was the presence of inﬂammatory cellsamples excised after 3 months.
Fig 4. Eosin-hematoxylin stain of tubular scaffold samples
excised after 3 months, showing accessory gland cells under
the neo-epithelium (100).
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epithelium of the neo bile duct there was a large number of
accessory gland cells (Fig 4). There were no differences in
epithelialization among the duodenal end, the central
portion, and the gallbladder end (Fig 5).DISCUSSION
With the advent of tissue engineering, the application of
completely resorbable biocompatible materials has become
an attractive investigational ﬁeld for their potential in
repairing or replacing nonfunctioning organs damaged by
aging or toxic agents [35,36].
Interesting scenarios are opened up by the possibility of
obtaining tubular resorbable scaffolds capable of promoting
the migration of the surrounding epithelium as a subse-
quently reabsorbed extracellular matrix, substituted with the
native tissue. The repair of biliary tree lesions with these
scaffolds has already been partially demonstrated by several
studies, particularly by Japanese authors. A group from
Saitama Medical University proposed the use of a copol-
ymer of PLA and PCL reinforced with ﬁbers of polyglycolic
acid [24]. The results at 6 months are encouraging, because
total resorption of the material used and formation of aFig 5. Longitudinal section of the neoebile duct after 3 months
of implantation. Arrow and arrowhead show two different tracts
of mucosa in the same longitudinal section.tissue completely uniform to the native anatomic structures
of the animal were noted.
The starting material of our scaffold is PHEA, a
biocompatible synthetic polymer soluble in water with a
structure similar to that of proteins. This macromolecule
was used for the synthesis of a PHEA-PLA copolymer,
which was obtained by the chemical binding of PHEA with
the biodegradable polymer PLA and of PLA with ethyl-
enediamine. The electrospinnable PHEA-PLA was then
mixed with another biodegradable polymer, PCL, in such a
way as to enable afﬁnity to the physiologic medium, chem-
ical versatility, and mechanical resistance to coexist in the
same material.
The data obtained from in vivo experiments showed that
the material has good biocompatibility, evoking an inﬂam-
matory response of modest degree, which has a key role in
the resorption of the material and in tissue regeneration,
leading to the migration of stem cells. The scaffold used for
this speciﬁc application had a length ofw1 cm, and its ﬁbers
had pores with a diameter ranging from 500 nm to 1 mm.
The 3-dimensional scaffold (PHEA-PLA/PCL) present-
ing the ﬁnal form of microﬁbrillar laminae was tested in this
2nd phase for its ability to withstand the chemical action of
bile. The data obtained after 15 days and 3 months of
implantation demonstrated that this electrospun scaffold
could be a potential candidate as substitute for the biliary
tree affected by injuries, because it shows good tissue inte-
gration and is resistant to the early lytic phenomena that
degrade the scaffold before complete colonization of cells,
as occurs for different scaffolds already tested for this
purpose.
After 3 months, the scaffold was recovered to assess its
biologic behavior toward the cellular constituents of the
gallbladder wall. The success of the present experiment was
essentially based on the demonstration of the resistance of
the scaffold to an aggressive environment, making it an ideal
candidate for the reparation of bile tract injuries.
CONCLUSION
Our biliary prosthetic material lends itself well to the
treatment of extrahepatic biliary tract injuries, because,
from the 1st data obtained, it was shown that the patch is
able to maintain its structural integrity. Its constituent ﬁbers
remain uniform and well organized, suggesting that this type
of material can withstand the corrosive action of bile acids.
These early results are of fundamental importance and
will lead us to carry out future studies that take into account
the ability of the scaffold to stimulate the homing of circu-
lating stem cells and the behavior of the cells placed in
direct contact with the material.
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